Mass spectrometry based quantitative proteomics and integrative network analysis accentuates modulating roles of annexin-1 in mammary tumorigenesis

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 408-418

  Swa, Hannah L F ^a   Shaik, Asfa Alli ^a   Lim, Lina H K ^b   Gunaratne, Jayantha ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Annexin 1; Breast cancer; Cell biology; Invasion metastasis; Network analysis; Quantitative proteomics

Indexed keywords

ANNEXIN; ANNEXIN 1; MYOSIN LIGHT CHAIN KINASE; UNCLASSIFIED DRUG; VIMENTIN; LIPOCORTIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL LYSATE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; MASS SPECTROMETRY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; EXPERIMENTAL MAMMARY NEOPLASM; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PROTEIN PROTEIN INTERACTION; UDDER;

ANIMALS; ANNEXIN A1; CARCINOGENESIS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PROTEIN INTERACTION MAPS; PROTEOMICS;

EID: 84921351198     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400175     Document Type: Article

References (47)

1. Crompton, M. R., Moss, S. E., Crumpton, M. J., Diversity in the lipocortin/calpactin family. Cell 1988, 55, 1-3.
2. Perretti, M., D'Acquisto, F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009, 9, 62-70.
3. D'Acquisto, F., Paschalidis, N., Raza, K., Buckley, C. D. et al., Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford) 2008, 47, 636-639.
4. D'Acquisto, F., Paschalidis, N., Sampaio, A. L., Merghani, A. et al., Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur. J. Immunol. 2007, 37, 3131-3142.
5. Davidson, J., Flower, R. J., Milton, A. S., Peers, S. H. et al., Antipyretic actions of human recombinant lipocortin-1. Br. J. Pharmacol. 1991, 102, 7-9.
6. Croxtall, J. D., Choudhury, Q., Tokumoto, H., Flower, R. J., Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity. Biochem. Pharmacol. 1995, 50, 465-474.
7. Kim, K. M., Kim, D. K., Park, Y. M., Kim, C. K. et al., Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 1994, 343, 251-255.
8. Croxtall, J. D., Waheed, S., Choudhury, Q., Anand, R. et al., N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int. J. Cancer 1993, 54, 153-158.
9. Skouteris, G. G., Schroder, C. H., The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem. 1996, 271, 27266-27273.
10. Solito, E., Kamal, A., Russo-Marie, F., Buckingham, J. C. et al., A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 2003, 17, 1544-1546.
11. Arur, S., Uche, U. E., Rezaul, K., Fong, M. et al., Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 2003, 4, 587-598.
12. de Coupade, C., Gillet, R., Bennoun, M., Briand, P. et al., Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000, 31, 371-380.
13. Bai, X. F., Ni, X. G., Zhao, P., Liu, S. M. et al., Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 2004, 10, 1466-1470.
14. Xin, W., Rhodes, D. R., Ingold, C., Chinnaiyan, A. M. et al., Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am. J. Pathol. 2003, 162, 255-261.
15. Hu, N., Flaig, M. J., Su, H., Shou, J. Z. et al., Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin. Cancer Res. 2004, 10, 6013-6022.
16. Garcia Pedrero, J. M., Fernandez, M. P., Morgan, R. O., Herrero Zapatero, A. et al., Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am. J. Pathol. 2004, 164, 73-79.
17. Yang, Y., Liu, Y., Yao, X., Ping, Y. et al., Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am. J. Pathol. 2011, 179, 1504-1512.
18. Yi, M., Schnitzer, J. E., Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc. Natl. Acad. Sci. USA 2009, 106, 17886-17891.
19. Babbin, B. A., Lee, W. Y., Parkos, C. A., Winfree, L. M. et al., Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 2006, 281, 19588-19599.
20. Ahn, S. H., Sawada, H., Ro, J. Y., Nicolson, G. L., Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin. Exp. Metastasis 1997, 15, 151-156.
21. de Graauw, M., van Miltenburg, M. H., Schmidt, M. K., Pont, C. et al., Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc. Natl. Acad. Sci. USA 2010, 107, 6340-6345.
22. Lund, R. R., Terp, M. G., Laenkholm, A. V., Jensen, O. N. et al., Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins. Proteomics 2012, 12, 2139-2148.
23. Bist, P., Leow, S. C., Phua, Q. H., Shu, S. et al., Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kappaB: implication in breast cancer metastasis. Oncogene 2011, 30, 3174-3185.
24. Swa, H. L., Blackstock, W. P., Lim, L. H., Gunaratne, J., Quantitative proteomics profiling of murine mammary gland cells unravels impact of annexin-1 on DNA damage response, cell adhesion, and migration. Mol. Cell. Proteomics 2012, 11, 381-393.
25. Hsu, J. L., Huang, S. Y., Chow, N. H., Chen, S. H., Stable-isotope dimethyl labeling for quantitative proteomics. Anal. Chem. 2003, 75, 6843-6852.
26. Boersema, P. J., Raijmakers, R., Lemeer, S., Mohammed, S. et al., Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 2009, 4, 484-494.
27. Wisniewski, J. R., Zougman, A., Nagaraj, N., Mann, M., Universal sample preparation method for proteome analysis. Nat. Methods 2009, 6, 359-362.
28. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A. et al., Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 2011, 10, 1794-1805.
29. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M. et al., STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, 41, D808-D815.
30. Dezso, Z., Nikolsky, Y., Nikolskaya, T., Miller, J. et al., Identifying disease-specific genes based on their topological significance in protein networks. BMC Syst. Biol. 2009, 3, 36.
31. Jiao, X., Sherman, B. T., Huang da, W., Stephens, R. et al., DAVID-WS: a stateful web service to facilitate gene/protein list analysis. Bioinformatics 2012, 28, 1805-1806.
32. Aslakson, C. J., Miller, F. R., Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52, 1399-1405.
33. Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J. P. et al., Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011, 30, 1436-1448.
34. Su, H. T., Weng, C. C., Hsiao, P. J., Chen, L. H. et al., Stem cell marker nestin is critical for TGF-beta1-mediated tumor progression in pancreatic cancer. Mol. Cancer Res. 2013, 11, 768-779.
35. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442-454.
36. Thiery, J. P., Acloque, H., Huang, R. Y., Nieto, M. A., Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139, 871-890.
37. Fife, C. M., McCarroll, J. A., Kavallaris, M., Movers and shakers: cell cytoskeleton in cancer metastasis. Br. J. Pharmacol. 2014. Doi: 10.1111/bph.12704
38. McGrath, J. L., Osborn, E. A., Tardy, Y. S., Dewey, C. F., Jr. et al., Regulation of the actin cycle in vivo by actin filament severing. Proc. Natl. Acad. Sci. USA 2000, 97, 6532-6537.
39. Parsons, J. T., Horwitz, A. R., Schwartz, M. A., Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 2010, 11, 633-643.
40. Zhou, X., Liu, Y., You, J., Zhang, H. et al., Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett. 2008, 270, 312-327.
41. Fazal, F., Gu, L., Ihnatovych, I., Han, Y. et al., Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol. Cell. Biol. 2005, 25, 6259-6266.
42. Somlyo, A. P., Somlyo, A. V., Signal transduction and regulation in smooth muscle. Nature 1994, 372, 231-236.
43. Totsukawa, G., Yamakita, Y., Yamashiro, S., Hartshorne, D. J. et al., Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J. Cell Biol. 2000, 150, 797-806.
44. Sanz-Moreno, V., Gaggioli, C., Yeo, M., Albrengues, J. et al., ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 2011, 20, 229-245.
45. Haynes, J., Srivastava, J., Madson, N., Wittmann, T. et al., Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol. Biol. Cell 2011, 22, 4750-4764.
46. Bist, P., Shu, S., Lee, H., Arora, S. et al., Annexin-A1 regulates TLR-mediated IFN-beta production through an interaction with TANK-binding kinase 1. J. Immunol. 2013, 191, 4375-4382.
47. Bedell, M. A., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Mouse models of human disease. Part II: recent progress and future directions. Genes Dev. 1997, 11, 11-43.